SCHEMBL198235

SCHEMBL198235

O=C1N(CO)C2C(N1CO)N(CO)C(=O)N2CO

nearest known ligand 0.76

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.76
GAA P10253 2/20 0.32
ADRA2C P18825 1/20 0.32
TP53 P04637 1/20 0.31
TSHR P16473 1/20 0.30
GBA1 P04062 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12858504 0.87 L3MBTL1 (1.00) L3MBTL1GAAADRA2CTP53GBA1
SCHEMBL12858469 0.82 L3MBTL1 (0.61) L3MBTL1GAAADRA2CTP53TSHR
SCHEMBL16867120 0.78 L3MBTL1 (0.52) L3MBTL1
SCHEMBL14385031 0.77 L3MBTL1 (0.55) L3MBTL1GAAADRA2CTP53TSHR
SCHEMBL13893200 0.77 L3MBTL1 (0.60) L3MBTL1GAA
SCHEMBL12418938 0.77 L3MBTL1 (0.56) L3MBTL1GBA1
SCHEMBL18106281 0.77 L3MBTL1 (0.50) L3MBTL1GAAADRA2CTP53TSHR
SCHEMBL18053224 0.77 L3MBTL1 (0.50) L3MBTL1
SCHEMBL13880283 0.76 L3MBTL1 (0.48) L3MBTL1
SCHEMBL13043581 0.74 L3MBTL1 (0.56) L3MBTL1GAATP53GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 877 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078296-A1 SUSTAINED-RELEASE SCALE INHIBITORS Materials Engineering and Technical Support Services (US) 2026-03-19 US claimed
US-20260041095-A1 A PRESERVATION METHOD ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-12 US claimed
US-20260034044-A1 A PRESERVATIVE COMPOSITION ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-05 US claimed
EP-4565196-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565197-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565065-A1 A PRESERVATION METHOD AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
US-20250075051-A1 PROCESS FOR RECYCLING CONTAMINATED POLYMERS ARKEMA FRANCE (FR) 2025-03-06 US claimed
EP-4516862-A1 AQUEOUS COATING COMPOSITION, COATING OBTAINED FROM THE COATING COMPOSITION, SUBSTRATE CONTAINING THE COATING AND THE USE OF THE AQUEOUS COATING COMPOSITION DAW SE (DE) 2025-03-05 EP claimed
EP-4457275-A1 PROCESS FOR RECYCLING CONTAMINATED POLYMERS ARKEMA FRANCE (FR) 2024-11-06 EP claimed
EP-4450128-A2 ANTIMICROBIAL COMPOSITIONS Symrise AG (DE) 2024-10-23 EP claimed
EP-1861464-A2 AQUEOUS SUSPENSIONS OR DISPERSIONS OF INORGANIC PIGMENTS CONTAINING A MIXTURE CONSISTING OF DIALDEHYDES AND FORMALDEHYDE CLEAVERS Bode Chemie GmbH & Co. (DE) 2007-12-05 EP claimed
EP-1684587-B1 MICROBICIDAL COMPOSITIONS AND THEIR USE BASF AG (DE) 2007-11-28 EP claimed
US-20070135391-A1 Microbicidal compositions and their use BASF AKTIENGESELLSCHAFT (DE) 2007-06-14 US claimed
WO-2006100042-A2 AQUEOUS SUSPENSIONS OR DISPERSIONS OF INORGANIC PIGMENTS CONTAINING A MIXTURE CONSISTING OF DIALDEHYDES AND FORMALDEHYDE CLEAVERS BODE CHEMIE GMBH & CO. (DE) 2006-09-28 WO claimed
EP-1684587-A1 MICROBICIDAL COMPOSITIONS AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 2006-08-02 EP claimed
EP-1679360-A1 Use of formaldehyde and formaldehyde-releasing compounds in a composition for controlling mycobacteria AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2006-07-12 EP claimed
US-20060142291-A1 Use of formaldehyde and formaldehyde-releasing compounds in a composition for controlling mycobacteria AIR LIQUIDE SANTE (INTERNATIONAL) (FR) 2006-06-29 US claimed
US-7008476-B2 Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof AZ ELECTRONIC MATERIALS USA CORP. (US) 2006-03-07 US claimed
WO-2005044010-A1 MICROBICIDAL COMPOSITIONS AND THEIR USE BASF AKTIENGESELLSCHAFT (DE) 2005-05-19 WO claimed
US-20040253532-A1 Modified alginic acid of alginic acid derivatives and thermosetting anti-reflective compositions thereof MERCK PATENT GMBH (DE) 2004-12-16 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041095-A1 A PRESERVATION METHOD LSS, ASAH2, CUTA L3MBTL1 374/4885GAA 405/4885ADRA2C 3757/4885
US-20260078296-A1 SUSTAINED-RELEASE SCALE INHIBITORS CEL, TST, CD44 L3MBTL1 2020/4885GAA 252/4885ADRA2C 3362/4885
US-20260034044-A1 A PRESERVATIVE COMPOSITION ERG28, FOXO3, DEGS1 L3MBTL1 1058/4885GAA 100/4885ADRA2C 1371/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.